NCT04725409 Neural Correlates of Psychiatric Disorders
| NCT ID | NCT04725409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University Medical Center |
| Condition | Psychiatric Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-03-31 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2021-03-31 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This ClincialTrials.gov record originally corresponded to the protocol approved under IRB # 202370. The study was expanded to include stimulation and recordings approved under new IRB #211037. The participant data originally acquired from IRB# 202370 will be included in this new record: This study seeks to better understand the neural activity underlying neuro cognitive disorders. Resting state local field potential recordings will be collected from medically refractory epilepsy patients implanted with depth electrodes for seizure localization, and metrics of neural activity will be correlated with psychiatric symptoms as measured from questionnaires. Subjects will also participate in neuro cognitive tasks while neural recordings are performed, and/or receive neural stimulation through implanted depth electrodes. A better understanding of disordered neural activity underlying neuropsychiatric disorders may additionally contribute to novel methods for diagnosing, treating, and preventing these diseases.
Eligibility Criteria
Inclusion Criteria: * Undergoing SEEG monitoring at Vanderbilt University Medical Center * At least 18 years of age * English speaking Exclusion Criteria: * Age \<18 * Not able to complete questionnaires (e.g., unable to comprehend instructions or follow directions)
Contact & Investigator
Sarah Bick, MD
PRINCIPAL INVESTIGATOR
Vanderbilt University Medical Center
Frequently Asked Questions
Who can join the NCT04725409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychiatric Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04725409 currently recruiting?
Yes, NCT04725409 is actively recruiting participants. Contact the research team at lucas.m.chang@vumc.org for enrollment information.
Where is the NCT04725409 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT04725409 clinical trial?
NCT04725409 is sponsored by Vanderbilt University Medical Center. The principal investigator is Sarah Bick, MD at Vanderbilt University Medical Center. The trial plans to enroll 100 participants.